ATE147261T1 - Verfahren zur herstellung von tabletten mit hoher festigkeit - Google Patents

Verfahren zur herstellung von tabletten mit hoher festigkeit

Info

Publication number
ATE147261T1
ATE147261T1 AT92920132T AT92920132T ATE147261T1 AT E147261 T1 ATE147261 T1 AT E147261T1 AT 92920132 T AT92920132 T AT 92920132T AT 92920132 T AT92920132 T AT 92920132T AT E147261 T1 ATE147261 T1 AT E147261T1
Authority
AT
Austria
Prior art keywords
high strength
producing high
strength tablets
binder
tablets
Prior art date
Application number
AT92920132T
Other languages
English (en)
Inventor
Julian Belknap Lo
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE147261T1 publication Critical patent/ATE147261T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT92920132T 1992-01-13 1992-09-10 Verfahren zur herstellung von tabletten mit hoher festigkeit ATE147261T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US81955392A 1992-01-13 1992-01-13

Publications (1)

Publication Number Publication Date
ATE147261T1 true ATE147261T1 (de) 1997-01-15

Family

ID=25228458

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92920132T ATE147261T1 (de) 1992-01-13 1992-09-10 Verfahren zur herstellung von tabletten mit hoher festigkeit

Country Status (12)

Country Link
US (1) US5853758A (de)
EP (1) EP0620728B1 (de)
JP (1) JP2640570B2 (de)
AT (1) ATE147261T1 (de)
CA (1) CA2117351C (de)
DE (1) DE69216642T2 (de)
DK (1) DK0620728T3 (de)
ES (1) ES2096103T3 (de)
FI (1) FI109086B (de)
GR (1) GR3022458T3 (de)
PT (1) PT101175B (de)
WO (1) WO1993013758A1 (de)

Families Citing this family (71)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438798B (en) * 1992-10-07 2001-06-07 Pfizer 3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
ES2076106B1 (es) * 1993-08-26 1996-06-16 Pfizer Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
WO1995026753A1 (en) * 1994-04-01 1995-10-12 Tsumura & Co. Process for producing sustained-release tablets and enteric tablets
KR19990022710A (ko) * 1995-06-07 1999-03-25 라잔 업펠 건조, 발포 유리 매트릭스에 물질을 안정하게 삽입시키는 방법 및 그 방법에 의해 얻어지는 조성물
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
RU2123330C1 (ru) * 1997-04-02 1998-12-20 Фармацевтическая фирма "Здоровье" Способ получения таблетированной формы препарата
US6413541B1 (en) 1999-01-13 2002-07-02 Dainippon Pharmaceutical Co., Ltd. Disintegrating tablet in oral cavity and production thereof
JP4504467B2 (ja) * 1998-07-30 2010-07-14 佐藤製薬株式会社 口腔内崩壊性錠剤
US20030026835A1 (en) * 1999-02-15 2003-02-06 Sumitomo Pharmaceuticals Company Limited Tablets disintegrating rapidly in the oral cavity
GB9908014D0 (en) 1999-04-08 1999-06-02 Scherer Corp R P Pharmaceutical compositions
GB2350582A (en) * 1999-06-01 2000-12-06 Hiran Asoka Malinga Ratwatte A method of tableting
US6277409B1 (en) 2000-02-11 2001-08-21 Mcneil-Ppc, Inc. Protective coating for tablet
US6258381B1 (en) 2000-02-11 2001-07-10 Mcneil-Ppc, Inc. Tablet and process for making the same
US20020015730A1 (en) * 2000-03-09 2002-02-07 Torsten Hoffmann Pharmaceutical formulations and method for making
KR20010107754A (ko) * 2000-05-26 2001-12-07 민경윤 경구투여용 속용정의 제조 방법
US20100015246A1 (en) * 2000-06-27 2010-01-21 Shire International Licensing B.V. Combination of a lanthanum compound and bone enhancing agent for the treatment of bone diseases
US6733781B2 (en) 2000-12-06 2004-05-11 Wyeth Fast dissolving tablet
US7799342B2 (en) * 2000-12-06 2010-09-21 Wyeth Llc Fast dissolving tablet
CA2350195C (en) * 2000-12-20 2003-06-10 Duchesnay Inc. Rapid onset formulation of pyridoxine hydrochloride and doxylamine succinate
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
EP1226818A1 (de) * 2001-01-26 2002-07-31 Pfizer Products Inc. Arzneiform mit verbesserten kohäsiven und kompressiven Eigenschaften
RU2296584C2 (ru) * 2001-04-23 2007-04-10 Шир Интернешнл Лайсенсин Б.В. Применение соединений редкоземельных металлов для предотвращения мочекаменной болезни
US6872405B2 (en) 2001-05-10 2005-03-29 Yamanouchi Pharmaceutical Co., Ltd. Quick-disintegrating tablet in buccal cavity and manufacturing method thereof
ATE333269T1 (de) * 2001-05-10 2006-08-15 Astellas Pharma Inc In der mundhöhle schnell zerfallende tabletten und prozess zu deren herstellung
RU2266744C2 (ru) * 2001-06-21 2005-12-27 Duchesnay Ink. Композиция быстрого начала действия
US6509040B1 (en) 2001-06-22 2003-01-21 R.P. Scherer Corporation Fast dispersing dosage forms essentially free of mammalian gelatin
US7914811B2 (en) 2001-06-29 2011-03-29 Mcneil-Ppc, Inc. Brittle-coating, soft core dosage form
NZ532097A (en) 2001-09-28 2006-02-24 Mcneil Ppc Inc Dosage forms having an inner core and outer shell
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
AU2003211051A1 (en) * 2002-02-13 2003-09-04 Michael K. Weibel Drug dose-form and method of manufacture
GB0204772D0 (en) * 2002-02-28 2002-04-17 Phoqus Ltd Pharmaceutical dosage forms
US20040109889A1 (en) 2002-12-04 2004-06-10 Bunick Frank J. Surface treatment composition for soft substrates
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
JP4896719B2 (ja) * 2003-08-26 2012-03-14 シャイアー ホールディングス アーゲー ランタン化合物を含む医薬製剤
US7381428B2 (en) * 2003-08-26 2008-06-03 Shire International Licensing B.V. Stabilized lanthanum carbonate compositions
US7282217B1 (en) 2003-08-29 2007-10-16 Kv Pharmaceutical Company Rapidly disintegrable tablets
US8591974B2 (en) * 2003-11-21 2013-11-26 Kraft Foods Global Brands Llc Delivery system for two or more active components as part of an edible composition
US8591973B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for active components and a material having preselected hydrophobicity as part of an edible composition
US8591972B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Delivery system for coated active components as part of an edible composition
US8591968B2 (en) 2005-05-23 2013-11-26 Kraft Foods Global Brands Llc Edible composition including a delivery system for active components
US8389032B2 (en) 2005-05-23 2013-03-05 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition having selected particle size
US20050112236A1 (en) 2003-11-21 2005-05-26 Navroz Boghani Delivery system for active components as part of an edible composition having preselected tensile strength
US8597703B2 (en) 2005-05-23 2013-12-03 Kraft Foods Global Brands Llc Delivery system for active components as part of an edible composition including a ratio of encapsulating material and active component
KR20070054191A (ko) * 2004-07-27 2007-05-28 샤이어 파마세우티컬, 인크. 란탄 하이드록시 카보네이트를 이용한 고인산증 치료 방법
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
US20060105039A1 (en) 2004-10-21 2006-05-18 Jin-Wang Lai Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
US9161918B2 (en) 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US20070104799A1 (en) * 2005-11-09 2007-05-10 Shire International Licensing B.V. Treatment of chronic kidney disease (CKD) subjects using lanthanum compounds
US20070207206A1 (en) * 2006-03-02 2007-09-06 Rice Bronwyn C Chewable pain formula
US20070259052A1 (en) * 2006-05-05 2007-11-08 Shire International Licensing B.V. Assay for lanthanum hydroxycarbonate
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
US20090068262A1 (en) * 2007-04-04 2009-03-12 Ilan Zalit Rapid dissolution of combination products
CA2704209C (en) 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Orally disintegrative dosage form
US8313768B2 (en) 2009-09-24 2012-11-20 Mcneil-Ppc, Inc. Manufacture of tablet having immediate release region and sustained release region
US20110070301A1 (en) 2009-09-24 2011-03-24 Luber Joseph R Orally transformable tablets
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
JP5309262B2 (ja) 2009-12-02 2013-10-09 アプタリス ファーマ リミテッド フェキソフェナジン・マイクロカプセル及びそれを含む組成物
RU2559406C2 (ru) 2011-04-29 2015-08-10 ИНТЕРКОНТИНЕНТАЛ ГРЕЙТ БРЭНДЗ ЭлЭлСи Инкапсулированная кислота, ее получение и содержащая ее композиция жевательной резинки
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
CN103432091A (zh) * 2013-09-13 2013-12-11 钟术光 一种性能改善的片剂及其制备方法
RU2712267C2 (ru) 2014-01-10 2020-01-28 Джонсон энд Джонсон Консьюмер Инк. Способ изготовления таблеток с использованием радиочастотного излучения и частиц с поглощающим покрытием
CN105769887B (zh) * 2014-12-23 2019-04-30 上海复星星泰医药科技有限公司 一种复方果糖二磷酸钠果糖口崩片及其制备方法
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
EP3389628A4 (de) 2015-12-19 2019-08-07 Dixit, Manesh A. Pharmazeutische formulierungen in form von weichen kautabletten
HRP20211247T1 (hr) * 2017-02-01 2021-11-12 Johnson & Johnson Consumer Inc. Pastila
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
JP7145121B2 (ja) 2019-05-31 2022-09-30 信越化学工業株式会社 錠剤の製造方法

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2987445A (en) * 1958-10-10 1961-06-06 Rohm & Haas Drug composition
NL297357A (de) * 1962-08-31
US4132753A (en) * 1965-02-12 1979-01-02 American Cyanamid Company Process for preparing oral sustained release granules
DE1617593A1 (de) * 1965-10-12 1971-04-29 Leo Pharm Prod Ltd Verfahren zur Herstellung von Tabletten oder Pillen
US3487138A (en) * 1966-11-23 1969-12-30 Merck & Co Inc Process for preparing a delayed release medicinal tablet
US3653914A (en) * 1970-03-20 1972-04-04 Alberto Culver Co Production of tablets
ZA723701B (en) * 1971-06-04 1973-04-25 Boehringer Mannheim Gmbh Process for the granulation of powdered tablet masses
DE2246013A1 (de) * 1972-09-20 1974-03-28 Boehringer Mannheim Gmbh Verfahren zur herstellung von poroesen tabletten
JPS5031022A (de) * 1973-05-29 1975-03-27
US3961004A (en) * 1974-04-11 1976-06-01 Auburn Research Foundation Method of tabletting using gluconolactone as the direct compression diluent
US3923939A (en) * 1974-06-07 1975-12-02 Alza Corp Process for improving release kinetics of a monolithic drug delivery device
JPS58403B2 (ja) * 1975-07-24 1983-01-06 武田薬品工業株式会社 Ｌ− アスコルビンサンセイザイノ セイゾウホウ
DE2556561C2 (de) * 1975-12-16 1983-04-14 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur Herstellung von porösen Tabletten
CA1097233A (en) * 1977-07-20 1981-03-10 George K. E. Gregory Packages
US4166107A (en) * 1978-07-25 1979-08-28 The United States Of America As Represented By The Secretary Of Agriculture Sustained release bolus formulations containing insect growth regulators for control of livestock pests
US4994227A (en) * 1986-03-10 1991-02-19 American Cyanamid Company Method for the preparation of sustained released bolus formulation
US4760094A (en) * 1986-10-21 1988-07-26 American Home Products Corporation (Del.) Spray dried acetaminophen
US5137669A (en) * 1988-03-02 1992-08-11 Endocon, Inc. Manufacture of partially fused peptide pellet
DE3812567A1 (de) * 1988-04-15 1989-10-26 Basf Ag Verfahren zur herstellung pharmazeutischer mischungen
LU87233A1 (fr) * 1988-06-07 1990-02-28 Pharlyse Sa Composition pharmaceutique a base d'un anti-inflammatoire non steroidien,son procede de preparation et son utilisation
US5036097A (en) * 1989-10-17 1991-07-30 Oklahoma Medical Research Foundation Phenylbutyl nitrone compositions and methods for prevention of gastric ulceration
WO1992011845A1 (en) * 1991-01-03 1992-07-23 Glaxo Canada Inc. Method for production of solid pharmaceutical preparation

Also Published As

Publication number Publication date
FI943327L (fi) 1994-07-12
JPH07503237A (ja) 1995-04-06
GR3022458T3 (en) 1997-04-30
PT101175B (pt) 1999-09-30
CA2117351A1 (en) 1993-07-22
DE69216642T2 (de) 1997-05-07
WO1993013758A1 (en) 1993-07-22
EP0620728A1 (de) 1994-10-26
ES2096103T3 (es) 1997-03-01
DK0620728T3 (da) 1997-07-07
DE69216642D1 (de) 1997-02-20
JP2640570B2 (ja) 1997-08-13
US5853758A (en) 1998-12-29
FI943327A0 (fi) 1994-07-12
EP0620728B1 (de) 1997-01-08
FI109086B (fi) 2002-05-31
CA2117351C (en) 1998-03-03
PT101175A (pt) 1994-03-31

Similar Documents

Publication Publication Date Title
ATE147261T1 (de) Verfahren zur herstellung von tabletten mit hoher festigkeit
DE58904479D1 (de) Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung.
HU9204033D0 (en) Substituted benzimidazoles, method for producing them and their pharmaceutical application
ES2020890A6 (es) Procedimiento de preparacion de una composicion farmaceutica en forma de microparticulas.
MY104065A (en) New pharmaceutical preparation
ATA125988A (de) Pharmazeutische cefuroximaxetil-zusammensetzung und verfahren zu ihrer herstellung
IL117532A0 (en) Production of compositions in the form of a solid solution of an active substance in a polymer matrix
HUT59558A (en) New 5-chloro-quinoline-8-oxy-alkane-carboxylic acid derivatives, process for producing and utilizing them as antidotum
DE3480705D1 (de) Gewisse 3-(5-aminopentyl)-amino-1-benzazepin-2-on-1-alkansaeuren, verfahren zu ihrer herstellung, pharmazeutische praeparate enthaltend diese verbindungen, sowie ihre therapeutische verwendung.
DE69023896D1 (de) Zementhilfsmittel, dessen herstellung sowie zementzusammensetzung.
FI943315A7 (fi) Farmaseuttinen valmiste pore- ja/tai hajoamistabletin tai pikarakeiden muodossa, samoin kuin menetelmä valmistaa niitä
DE69721489D1 (de) Herstellungsverfahren von löslichen verabreichungssystemen unter verwendung von flüchtigen salzen
ATE117294T1 (de) Chinolin-derivate, verfahren zu ihrer herstellung und ihre anwendung als arzneimittel.
DE69107949D1 (de) MOS-gesteuerter Thyristor und Verfahren zu dessen Herstellung.
NL8901652A (nl) Carboxamideverbindingen, werkwijzen ter bereiding hiervan en farmaceutische preparaten, die deze bevatten.
ATE23110T1 (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung.
DE59003581D1 (de) Hochtemperatur-Verbund-Werkstoff, Verfahren zu seiner Herstellung sowie dessen Verwendung.
DE68908374D1 (de) Propenonoximether, verfahren zu dessen herstellung sowie diese enthaltende arzneinmittel.
DE3483899D1 (de) Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische praeparate.
HU9203828D0 (en) Method for producing cristallic alpha-2-interferon
DE3483308D1 (de) Semicarbazid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ZA911538B (en) New benzimidazole derivatives,process for their production and their pharmaceutical use
KR930702004A (ko) 세파로스포란 산 유도체를 함유하는 정제를 제조하기 위한 직접 압축 방법
NO974838D0 (no) Fremgangsmåte for fremstilling av formlegemer
DE68912944D1 (de) Phenylpyrole, verwendbar als arzneimittel, verfahren zu ihrer herstellung und ihre verwendung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee